Reata Pharmaceuticals, Inc. Free Cash Flow 2016-2023 | RETA
Reata Pharmaceuticals, Inc. free cash flow from 2016 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Reata Pharmaceuticals, Inc. Annual Free Cash Flow |
| 2022 |
-207.54 |
| 2021 |
-237.03 |
| 2020 |
-323.27 |
| 2019 |
-253.82 |
| 2018 |
-84.46 |
| 2017 |
-83.60 |
| 2016 |
-19.60 |
| 2015 |
-44.89 |
| 2014 |
-88.81 |
| Reata Pharmaceuticals, Inc. Quarterly Free Cash Flow |
| 2023-06-30 |
-151.79 |
| 2023-03-31 |
-81.59 |
| 2022-12-31 |
-207.54 |
| 2022-09-30 |
-156.74 |
| 2022-06-30 |
-109.87 |
| 2022-03-31 |
-58.47 |
| 2021-12-31 |
-237.03 |
| 2021-09-30 |
-113.91 |
| 2021-06-30 |
-71.07 |
| 2021-03-31 |
-45.20 |
| 2020-12-31 |
-323.27 |
| 2020-09-30 |
-277.74 |
| 2020-06-30 |
-237.49 |
| 2020-03-31 |
-41.26 |
| 2019-12-31 |
-253.82 |
| 2019-09-30 |
-104.20 |
| 2019-06-30 |
-63.53 |
| 2019-03-31 |
-29.89 |
| 2018-12-31 |
-84.46 |
| 2018-09-30 |
-46.66 |
| 2018-06-30 |
-49.70 |
| 2018-03-31 |
-24.17 |
| 2017-12-31 |
-83.60 |
| 2017-09-30 |
-58.73 |
| 2017-06-30 |
-39.55 |
| 2017-03-31 |
-22.09 |
| 2016-12-31 |
-19.60 |
| 2016-09-30 |
-8.40 |
| 2016-06-30 |
-12.01 |
| 2016-03-31 |
0.80 |
| 2015-12-31 |
-44.89 |
| 2015-09-30 |
-32.33 |
| 2015-06-30 |
-21.46 |
| 2015-03-31 |
-8.74 |
